The trouble with Ostarine: Jimmy Wallhead’s
16th March 2018
Features
The ITA asserts an apparent ADRV against Bahrain track and field athlete Alsadik Mikhou
• The International Testing Agency (ITA) reports that a sample collected from Alsadik Mikhou, runner from Bahrain, has retuned an adverse analytical finding for homologous blood transfusion (M.1 Prohibited Method – manipulation of blood).
The sample was collected by the ITA under the Testing Authority of the International Olympic Committee (IOC) during an out-of-competition anti-doping control on 2 August 2021 in Tokyo, Japan. The result was reported by the WADA-accredited laboratory of Tokyo on 6 August 2021.
The athlete, who participated in the heats of the Men’s 1500m Round 1 of the Olympic Games Tokyo 2020 on 3 August 2021 without qualifying for the semi-finals, has been provisionally suspended until the resolution of the matter in line with the World Anti-Doping Code and the IOC Anti-Doping Rules. The athlete has the right to challenge the imposition of the provisional suspension before the Court of Arbitration for Sport – Anti-Doping Division.
The athlete also has the right to request the analysis of the B-sample. Given that the case is underway, there will be no further comments during the ongoing proceeding.
• This media release was published by the International Testing Agency (ITA) on 8 August 2021. Click here for the original.
